Herein, the dimeric Her2-specific affibody-mediated nanoparticles, denoted Pt@mPDA/MnO2/PDA-ZHer2 NPs, were developed to enhance MRI imaging and chemo-radiotherapy of Her2-overexpressing ovarian cancer. Here, ERBB2 is linked to ovarian carcinoma.